Season 10 · Episode 9
S10 Ep9: FDA Approval Insights: Pirtobrutunib in Previously Treated CLL/SLL
OncLive® On Air · OncLive® On Air
January 25, 202410m 54s
Audio is streamed directly from the publisher (audioboom.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr Davids discusses the FDA approval of pirtobrutinib for patients with previously treated CLL/SLL; key efficacy and safety data from the BRUIN trial; and guidelines for pirtobrutinib use in clinical practice in the CLL/SLL patient population.